Skip to content

Evaluation of intestinal peristalsis with oral drugs that inhibit gastrointestinal peristalsis.

Evaluation of intestinal peristalsis with oral drugs that inhibit gastrointestinal peristalsis. - Evaluation of intestinal peristalsis with oral drugs that inhibit gastrointestinal peristalsis.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000051547
Enrollment
10
Registered
2023-07-07
Start date
2023-03-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional gastrointestinal disorders

Interventions

Abdominal ultrasound or breath test

Sponsors

Kyoto Prefectural University of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adults with abdominal discomfort or patients taking drugs that inhibit gastrointestinal peristalsis.

Exclusion criteria

Exclusion criteria: 1) obvious infection or inflammation, , 2) serious complications (intestinal paralysis, intestinal obstruction, interstitial pneumonia or pulmonary fibrosis, diabetes mellitus that is difficult to control, renal failure, liver cirrhosis), 3) postoperative inflammatory bowel disease of esophagus, stomach, duodenum, or large intestine, 4) deemed by the physician to be inappropriate for this study, 5) Under 20 years old

Design outcomes

Primary

MeasureTime frame
Evaluation of changes in peristalsis before and after oral administration of Shakuyakukanzoto and oter drugs by external abdominal ultrasonography

Secondary

MeasureTime frame
Measure the intestinal diameter (maximum diameter) by measuring the diameter of the intestinal tract drawn in the longitudinal direction before and after taking drug. Evaluate the elevated values of hydrogen and methane gas concentrations by breath test results.

Countries

Japan

Contacts

Public ContactReo Kobayashi

Kyoto Prefectural University of Medicine, Graduate School of Medical Science Department of Gastroenterology and Hepatology

reipanna@koto.kpu-m.ac.jp0752515111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026